A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment. 1. Juni 2011 Mross, K., Büchert, M., Fasol, U., Jaehde, U., Kanefendt, F., Strumberg, D., Arends, J., Hense, J., Moritz, B., Fischer, R., Scheulen, M.E., 2011. Int J Clin Pharmacol Ther 49, 96–98. Abstract Networking Against Cancer. Marschner, N., Jänicke, M., 2011. Breast Care 6, 245–247. doi:10.1159/000329716 Abstract… Weiterlesen Real-life treatment of patients with advanced or metastatic renal cell carcinoma in German oncology and urology outpatient centers (RCC-Registry). Müller, L., Goebell, P.J., Blumenstengel, K., Lueck, A., Koska, M., Marschner, N., 2011. J Clin Oncol 29 (suppl 7)(Abstract 367). doi:10.1200/jco.2011.29.7_suppl.367… Weiterlesen